Executive Director, BC Children’s Hospital Research Institute
Associate Dean for Research, Faculty of Medicine
Senior Scientist, Centre for Molecular Medicine and Therapeutics
Professor, Department of Medical Genetics
University of British Columbia
Wyeth Wasserman, Ph.D., has worked in the biotechnology and pharmaceutical industry in both North America and Europe, focused on research projects with applied biomedical impacts. His computational biology laboratory develops computer algorithms for the analysis of human DNA sequences.
Originally established at Sweden’s Karolinska Institute and since 2002 at the University of British Columbia, Dr. Wasserman’s lab provides international leadership in the identification and engineered design of DNA sequences that control when and where in the body each gene is active – the On and Off switches. With the arrival of low cost DNA sequencing for patients, his team works closely with clinicians at BC Children’s Hospital to discover the genetic causes impacting patients and families.
With undergraduate degrees in mathematics and molecular cell biology from the University of Washington and a PhD in oncology from the University of Wisconsin, Dr. Wasserman brings a quantitative perspective to genetics research. He has published over 120 peer-reviewed papers, participated in over $15 million of funded research, and supervised more than 60 graduate and post-doctoral trainees.
Dr. Wasserman has served as Principal Investigator or Co-Principal Investigator on nine projects supported by Genome Canada and/or Genome British Columbia. Since 2013, he has served as the Executive Director of the BC Children’s Hospital Research Institute.